Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Psoriatic Arthritis and Risk of Vertebral Fracture: A Systematic Review and Meta-Analysis

Author(s): Nipith Charoenngam, Ben Ponvilawan, Jerapas Thongpiya*, Pitchaporn Yingchoncharoen and Patompong Ungprasert

Volume 18, Issue 1, 2022

Published on: 08 September, 2021

Page: [64 - 71] Pages: 8

DOI: 10.2174/1573397117666210908094349

Price: $65

Abstract

Objective: This study was conducted in order to determine the association between psoriatic arthritis and the risk of vertebral fracture by pooling the evidence from previous studies.

Methods: Potentially eligible studies were identified from MEDLINE and EMBASE databases from inception to March 2020 using a search strategy that comprised of terms “Psoriatic Arthritis” and “Vertebral Fracture”. Studies were eligible for the meta-analysis if they were cohort studies that included psoriatic arthritis and individuals without psoriasis and followed them for incident vertebral fracture. Studies were also required to report standardized incidence ration, hazard risk ratio or relative risk with related 95% confidence intervals (CI) comparing the incidence of vertebral fracture between the two cohorts. The retrieved point estimates with standard errors from each study were pooled into the final result by the random-effect model and generic inverse variance method.

Results: A total of 26,090 articles were identified. After two rounds of independent review by three investigators, we included five cohort studies that met the eligibility criteria in the meta-analysis. PsA is significantly associated with VF with a pooled odds ratio of 2.09 (95% CI, 1.11 – 3.96; I2 70%). The funnel plot was fairly asymmetric, thus the publication bias in favor of studies may present.

Conclusion: This systematic review and meta-analysis indicates that psoriatic arthritis patients have a significantly elevated risk of developing a vertebral fracture.

Keywords: Psoriatic arthritis, vertebral fracture, meta-analysis, osteoporosis, back pain, inflammatory disorder.

« Previous Next »
[1]
Waterloo S, Ahmed LA, Center JR, et al. Prevalence of vertebral fractures in women and men in the population-based Tromsø Study. BMC Musculoskelet Disord 2012; 13: 3.
[http://dx.doi.org/10.1186/1471-2474-13-3] [PMID: 22251875]
[2]
Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 2017; 28(5): 1531-42.
[http://dx.doi.org/10.1007/s00198-017-3909-3] [PMID: 28168409]
[3]
Nevitt MC, Cummings SR, Stone KL, et al. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 2005; 20(1): 131-40.
[http://dx.doi.org/10.1359/jbmr.2005.20.1.131] [PMID: 15619679]
[4]
Lems WF. Clinical relevance of vertebral fractures. Ann Rheum Dis 2007; 66(1): 2-4.
[http://dx.doi.org/10.1136/ard.2006.058313] [PMID: 17178757]
[5]
Edidin AA, Ong KL, Lau E, Kurtz SM. Life expectancy following diagnosis of a vertebral compression fracture. Osteoporos Int 2013; 24(2): 451-8.
[http://dx.doi.org/10.1007/s00198-012-1965-2] [PMID: 22422305]
[6]
Kendler DL, Bauer DC, Davison KS, et al. Vertebral fractures: Clinical importance and management. Am J Med 2016; 129(2): 221.e1-e10.
[7]
Baaj AA, Downes K, Vaccaro AR, Uribe JS, Vale FL. Trends in the treatment of lumbar spine fractures in the United States: a socioeconomics perspective: clinical article. J Neurosurg Spine 2011; 15(4): 367-70.
[http://dx.doi.org/10.3171/2011.5.SPINE10934] [PMID: 21740124]
[8]
Sankowski AJ, Lebkowska UM, Cwikła J, Walecka I, Walecki J. Psoriatic arthritis. Pol J Radiol 2013; 78(1): 7-17.
[http://dx.doi.org/10.12659/PJR.883763] [PMID: 23493653]
[9]
Ocampo D V, Gladman D. Psoriatic arthritis.F1000Res. F1000 faculty 2019; 8. Rev-665
[http://dx.doi.org/10.12688/f1000research.19144.1] [PMID: 31583079]
[10]
Liu J-T, Yeh H-M, Liu S-Y, Chen K-T. Psoriatic arthritis: Epidemiology, diagnosis, and treatment. World J Orthop 2014; 5(4): 537-43.
[http://dx.doi.org/10.5312/wjo.v5.i4.537] [PMID: 25232529]
[11]
Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011; 22(2): 421-33.
[http://dx.doi.org/10.1007/s00198-010-1319-x] [PMID: 20552328]
[12]
Xue AL, Wu S-Y, Jiang L, Feng A-M, Guo H-F, Zhao P. Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 2017; 96(36): e6983-.
[http://dx.doi.org/10.1097/MD.0000000000006983]
[13]
Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Jiménez-Herrera EA, León-Vázquez MdlL, Montiel-Jarquín Á. Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression. PLoS one 2018; 13(6): e0196113-.
[14]
Chen J, Lei L, Pan J, Zhao C. A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clin Rheumatol 2020; 39(4): 1181-9.
[http://dx.doi.org/10.1007/s10067-019-04847-0] [PMID: 31838641]
[15]
Merola JF, Espinoza LR, Fleischmann R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open 2018; 4(2): e000656.
[http://dx.doi.org/10.1136/rmdopen-2018-000656] [PMID: 30167326]
[16]
Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001; 28(1): 138-43.
[PMID: 11196516]
[17]
Samakhavets VY, Rudenka EV, Adamenka AV. State of bone mineral density and the prevalence of vertebral deformities in patients with psoriatic arthritis. Osteoporos Int 2012; 23: S231-.
[18]
Zhu TY, Griffith JF, Qin L, et al. Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.Osteoporos Int. 2015; 26: pp. (1)261-72.
[19]
Del Puente A, Esposito A, Costa L, et al. Fragility fractures in patients with psoriatic arthritis. J Rheumatol Suppl 2015; 93: 36-9.
[http://dx.doi.org/10.3899/jrheum.150633] [PMID: 26523054]
[20]
Kathuria P, Gordon KB, Silverberg JI. Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures. J Am Acad Dermatol 2017; 76(6): 1045-1053.e3.
[http://dx.doi.org/10.1016/j.jaad.2016.11.046] [PMID: 28314685]
[21]
Giudice LL, Zucaro NMM, Gallego JFJ, Pierini FS, Scolnik M, Guppy ERS. Fragility fractures in psoriatic arthritis patients: A matched-control study. J Clin Rheumatol 2019; 25(3): S62.
[22]
Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
[23]
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
[http://dx.doi.org/10.1016/0197-2456(86)90046-2] [PMID: 3802833]
[24]
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[25]
Kastelan D, Kastelan M, Massari LP, Korsic M. Possible association of psoriasis and reduced bone mineral density due to increased TNF-α and IL-6 concentrations. Med Hypotheses 2006; 67(6): 1403-5.
[http://dx.doi.org/10.1016/j.mehy.2006.04.069] [PMID: 16844318]
[26]
Zhang Y-H, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-α (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 2001; 276(1): 563-8.
[http://dx.doi.org/10.1074/jbc.M008198200] [PMID: 11032840]
[27]
Wu Q, Zhou X, Huang D, Ji Y, Kang F. IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro. Cell Physiol Biochem 2017; 41(4): 1360-9.
[http://dx.doi.org/10.1159/000465455] [PMID: 28278513]
[28]
Luo G, Li F, Li X, Wang Z-G, Zhang B. TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway. Mol Med Rep 2018; 17(5): 6605-11.
[http://dx.doi.org/10.3892/mmr.2018.8698] [PMID: 29512766]
[29]
Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 2000; 160(19): 2917-22.
[http://dx.doi.org/10.1001/archinte.160.19.2917] [PMID: 11041898]
[30]
Mirza F, Canalis E. Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015; 173(3): R131-51.
[http://dx.doi.org/10.1530/EJE-15-0118] [PMID: 25971649]
[31]
Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009; 68(9): 1387-94.
[http://dx.doi.org/10.1136/ard.2008.094946] [PMID: 18952643]
[32]
Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD open 2015; 1(1): e000014.
[http://dx.doi.org/10.1136/rmdopen-2014-000014]
[33]
Cuchacovich R, Perez-Alamino R, Garcia-Valladares I, Espinoza LR. Steps in the management of psoriatic arthritis: a guide for clinicians. Ther Adv Chronic Dis 2012; 3(6): 259-69.
[http://dx.doi.org/10.1177/2040622312459673] [PMID: 23342240]
[34]
Tucker LJ, Coates LC, Helliwell PS. Assessing disease activity in psoriatic arthritis: A literature review. Rheumatol Ther 2019; 6(1): 23-32.
[http://dx.doi.org/10.1007/s40744-018-0132-4] [PMID: 30471015]
[35]
Carter MI, Hinton PS. Physical activity and bone health. Mo Med 2014; 111(1): 59-64.
[PMID: 24645301]
[36]
Holick MF, Vitamin D. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[37]
Petho Z, Kulcsar-Jakab E, Kalina E, et al. Vitamin D status in men with psoriatic arthritis: a case-control study. Osteoporos Int 2015; 26(7): 1965-70.
[http://dx.doi.org/10.1007/s00198-015-3069-2] [PMID: 25693749]
[38]
Kincse G, Bhattoa PH, Herédi E, et al. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol 2015; 42(7): 679-84.
[http://dx.doi.org/10.1111/1346-8138.12876] [PMID: 25959376]
[39]
Filoni A, Vestita M, Congedo M, Giudice G, Tafuri S, Bonamonte D. Association between psoriasis and vitamin D: Duration of disease correlates with decreased vitamin D serum levels: An observational case-control study. Medicine (Baltimore) 2018; 97(25): e11185-.
[40]
Al-Dhubaibi MS. Association between Vitamin D deficiency and psoriasis: An exploratory study. Int J Health Sci (Qassim) 2018; 12(1): 33-9.
[PMID: 29623015]
[41]
Pitukweerakul S, Thavaraputta S, Prachuapthunyachart S, Karnchanasorn R. Hypovitaminosis D is associated with psoriasis: A systematic review and meta-analysis. Kans J Med 2019; 12(4): 103-8.
[http://dx.doi.org/10.17161/kjm.v12i4.13255] [PMID: 31803350]
[42]
Bikle DD. Vitamin D and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord 2012; 13(1): 3-19.
[http://dx.doi.org/10.1007/s11154-011-9194-0] [PMID: 21845365]
[43]
Cantorna MT, Snyder L, Lin Y-D, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients 2015; 7(4): 3011-21.
[http://dx.doi.org/10.3390/nu7043011] [PMID: 25912039]
[44]
Thorin MH, Wihlborg A, Åkesson K, Gerdhem P. Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 2016; 27(1): 249-55.
[http://dx.doi.org/10.1007/s00198-015-3290-z] [PMID: 26302684]
[45]
Pezzolo E, Naldi L. The relationship between smoking, psoriasis and psoriatic arthritis. Expert Rev Clin Immunol 2019; 15(1): 41-8.
[http://dx.doi.org/10.1080/1744666X.2019.1543591] [PMID: 30380949]
[46]
Al-Bashaireh AM, Haddad LG, Weaver M, Chengguo X, Kelly DL, Yoon S. The effect of tobacco smoking on bone mass: An overview of pathophysiologic mechanisms. J Osteoporos 2018; 2018: 1206235.
[http://dx.doi.org/10.1155/2018/1206235] [PMID: 30631414]
[47]
Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014; 170(2): 304-14.
[http://dx.doi.org/10.1111/bjd.12670] [PMID: 24117435]
[48]
Ogdie A, Gelfand JM. Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: A review of available evidence. Curr Rheumatol Rep 2015; 17(10): 64.
[http://dx.doi.org/10.1007/s11926-015-0540-1] [PMID: 26290111]

Rights & Permissions Print Cite
Article Metrics
21
1
© 2024 Bentham Science Publishers | Privacy Policy